{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:53:13Z","timestamp":1781023993341,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,10]]},"DOI":"10.7759\/cureus.20319","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T11:00:16Z","timestamp":1639134016000},"source":"Crossref","is-referenced-by-count":4,"title":["Potential Psychotropic and COVID-19 Drug Interactions: A Comparison of Integrated Evidence From Six Database Programs"],"prefix":"10.7759","author":[{"given":"Javedh","family":"Shareef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathvik","family":"Belagodu Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiqulla","family":"Shariff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriharsha","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.18308","article-title":"Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations","volume":"18","author":"Ostuzzi G","year":"2020","unstructured":"Ostuzzi G, Papola D, Gastaldon C, et al.. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. Focus. 2020, 18:466-81. 10.1176\/appi.focus.18308","journal-title":"Focus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00811-2","article-title":"Clinically significant drug interactions between psychotropic agents and repurposed COVID-19 therapies","volume":"35","author":"Gatti M","year":"2021","unstructured":"Gatti M, De Ponti F, Pea F. Clinically significant drug interactions between psychotropic agents and repurposed COVID-19 therapies. CNS Drugs. 2021, 35:345-84. 10.1007\/s40263-021-00811-2","journal-title":"CNS Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.633230","article-title":"Impact of the coronavirus pandemic (COVID-19) lockdown on mental health and well-being in the United Arab Emirates","volume":"12","author":"Cheikh Ismail L","year":"2021","unstructured":"Cheikh Ismail L, Mohamad MN, Bataineh MF, et al.. Impact of the coronavirus pandemic (COVID-19) lockdown on mental health and well-being in the United Arab Emirates. Front Psychiatry. 2021, 12:633230. 10.3389\/fpsyt.2021.633230","journal-title":"Front Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2020.11.006","article-title":"Potential drug interactions of repurposed COVID-19 drugs with lung cancer pharmacotherapies","volume":"52","author":"Baburaj G","year":"2021","unstructured":"Baburaj G, Thomas L, Rao M. Potential drug interactions of repurposed COVID-19 drugs with lung cancer pharmacotherapies. Arch Med Res. 2021, 52:261-9. 10.1016\/j.arcmed.2020.11.006","journal-title":"Arch Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2020-002419","article-title":"Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?","volume":"28","author":"Yal\u00e7\u0131n N","year":"2021","unstructured":"Yal\u00e7\u0131n N, Ak S, Demirkan K. Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?. Eur J Hosp Pharm. 2021, 28:e2. 10.1136\/ejhpharm-2020-002419","journal-title":"Eur J Hosp Pharm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2020-0145","article-title":"Clinically important drug-drug interactions in patients admitted to hospital with COVID-19: drug pairs, risk factors, and management","volume":"36","author":"Mahboobipour AA","year":"2020","unstructured":"Mahboobipour AA, Baniasadi S. Clinically important drug-drug interactions in patients admitted to hospital with COVID-19: drug pairs, risk factors, and management. Drug Metab Pers Ther. 2020, 36:9-16. 10.1515\/dmpt-2020-0145","journal-title":"Drug Metab Pers Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2020.5010","article-title":"Drug-drug interaction between psychiatric medications and experimental treatments for coronavirus disease-19: a mini-review","volume":"8","author":"Baradaran H","year":"2020","unstructured":"Baradaran H, Gorgzadeh N, Seraj H, Asadi A, Shamshirian D, Rezapour M.. Drug-drug interaction between psychiatric medications and experimental treatments for coronavirus disease-19: a mini-review. Open Access Macedonian J Med Sci. 2020, 8:216-28. 10.3889\/oamjms.2020.5010","journal-title":"Open Access Macedonian J Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.102545","article-title":"Assessment of drug-drug interactions among renal failure patients of nephrology ward in a South Indian tertiary care hospital","volume":"74","author":"Rama M","year":"2012","unstructured":"Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV. Assessment of drug-drug interactions among renal failure patients of nephrology ward in a South Indian tertiary care hospital. Indian J Pharm Sci. 2012, 74:63-8. 10.4103\/0250-474X.102545","journal-title":"Indian J Pharm Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-7-7","article-title":"Clinical decision support tools: analysis of online drug information databases","volume":"7","author":"Clauson KA","year":"2007","unstructured":"Clauson KA, Marsh WA, Polen HH, Seamon MJ, Ortiz BI. Clinical decision support tools: analysis of online drug information databases. BMC Med Inform Decis Mak. 2007, 7:7. 10.1186\/1472-6947-7-7","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0221-y","article-title":"An overview of clinical decision support systems: benefits, risks, and strategies for success","volume":"3","author":"Sutton RT","year":"2020","unstructured":"Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020, 3:17. 10.1038\/s41746-020-0221-y","journal-title":"NPJ Digit Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocx010","article-title":"Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support","volume":"24","author":"Fung KW","year":"2017","unstructured":"Fung KW, Kapusnik-Uner J, Cunningham J, Higby-Baker S, Bodenreider O. Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support. J Am Med Inform Assoc. 2017, 24:806-12. 10.1093\/jamia\/ocx010","journal-title":"J Am Med Inform Assoc"},{"key":"ref12","unstructured":"Truven Health Analytics, Inc. Drug Interactions. (2021). Accessed. July 10,2021: https:\/\/www.micromedexsolutions.com\/home\/dispatch\/ssl\/true."},{"key":"ref13","unstructured":"Portable Electronic Physician Information Databse, LLc. Drug Interactions. (2021). Accessed. July 13, 2021: https:\/\/pepidconnect.com."},{"key":"ref14","unstructured":"Drug Interactions. Lexicomp. Wolters Kluwer Health, Inc.. (2021). Accessed. July 16, 2021: https:\/\/online.lexi.com."},{"key":"ref15","unstructured":"Medscape LLC. Medscape.com drug interaction checker. (1994-2021). Accessed. July 21, 2021: https:\/\/reference.medscape.com\/drug-interactionchecker."},{"key":"ref16","unstructured":"Drugsite Trust. Drugs.com drug interaction checker. (2021). Accessed. July 25, 2021: https:\/\/www.drugs.com\/drug_interactions.html."},{"key":"ref17","unstructured":"WebMD LLC. WebMD.com drug interaction checker. (2021). Accessed. July 27, 2021: https:\/\/www.webmd.com\/interaction-checker\/default.htm."},{"key":"ref18","unstructured":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. (2021). Accessed. June 10, 2021: https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"ref19","unstructured":"Therapeutics and COVID- 19. living guideline. World Health Organization. (2021). Accessed: June 13, 2021: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/342368\/WHO-2019-nCoV-therapeutics-2021.2-eng.pdf."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5195\/jmla.2019.549","article-title":"Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions","volume":"107","author":"Beckett RD","year":"2019","unstructured":"Beckett RD, Stump CD, Dyer MA. Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions. J Med Libr Assoc. 2019, 107:62-71. 10.5195\/jmla.2019.549","journal-title":"J Med Libr Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3163\/1536-5050.104.4.007","article-title":"Evaluation of resources for analyzing drug interactions","volume":"104","author":"Patel RI","year":"2016","unstructured":"Patel RI, Beckett RD. Evaluation of resources for analyzing drug interactions. J Med Libr Assoc. 2016, 104:290-5. 10.3163\/1536-5050.104.4.007","journal-title":"J Med Libr Assoc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.03.041","article-title":"A comparison of potential psychiatric drug interactions from six drug interaction database programs","volume":"275","author":"Monteith S","year":"2019","unstructured":"Monteith S, Glenn T. A comparison of potential psychiatric drug interactions from six drug interaction database programs. Psychiatry Res. 2019, 275:366-72. 10.1016\/j.psychres.2019.03.041","journal-title":"Psychiatry Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05716-4","article-title":"Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review","volume":"238","author":"Plasencia-Garc\u00eda BO","year":"2021","unstructured":"Plasencia-Garc\u00eda BO, Rodr\u00edguez-Men\u00e9ndez G, Rico-Rangel MI, Rubio-Garc\u00eda A, Torell\u00f3-Iserte J, Crespo-Facorro B. Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review. Psychopharmacology. 2021, 238:329-40. 10.1007\/s00213-020-05716-4","journal-title":"Psychopharmacology"},{"key":"ref24","article-title":"Drug interactions between COVID-19 and psychiatric medications: a mini review","volume":"7","author":"Izci F","year":"2020","unstructured":"Izci F, Kulacaoglu F. Drug interactions between COVID-19 and psychiatric medications: a mini review. J Neurobehav Sci. 2020, 7:103-8.","journal-title":"J Neurobehav Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2020.84","article-title":"Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders","volume":"217","author":"Zhang K","year":"2020","unstructured":"Zhang K, Zhou X, Liu H, Hashimoto K. Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders. Br J Psychiatry. 2020, 217:351. 10.1192\/bjp.2020.84","journal-title":"Br J Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13766","article-title":"Assessing consistency of drug-drug interaction-related information across various drug information resources","volume":"13","author":"Shariff A","year":"2021","unstructured":"Shariff A, Belagodu Sridhar S, Abdullah Basha NF, Bin Taleth Alshemeil SS, Ahmed Aljallaf Alzaabi NA 4th. Assessing consistency of drug-drug interaction-related information across various drug information resources. Cureus. 2021, 13:e13766. 10.7759\/cureus.13766","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00086","article-title":"Comparison of nine tools for screening drug-drug interactions of oral oncolytics","volume":"14","author":"Marcath LA","year":"2018","unstructured":"Marcath LA, Xi J, Hoylman EK, Kidwell KM, Kraft SL, Hertz DL. Comparison of nine tools for screening drug-drug interactions of oral oncolytics. J Oncol Pract. 2018, 14:e368-74. 10.1200\/JOP.18.00086","journal-title":"J Oncol Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2802","article-title":"Comparison of potential psychiatric drug interactions in six drug interaction database programs: a replication study after 2\u00a0years of updates","volume":"36","author":"Monteith S","year":"2021","unstructured":"Monteith S, Glenn T. Comparison of potential psychiatric drug interactions in six drug interaction database programs: a replication study after 2\u00a0years of updates. Hum Psychopharmacol. 2021, 36:e2802. 10.1002\/hup.2802","journal-title":"Hum Psychopharmacol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5195\/jmla.2020.969","article-title":"Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse","volume":"108","author":"Beckett RD","year":"2020","unstructured":"Beckett RD, Martin JR, Stump CD, Dyer MA. Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse. J Med Libr Assoc. 2020, 108:584-90. 10.5195\/jmla.2020.969","journal-title":"J Med Libr Assoc"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1055\/a-1156-4193","article-title":"Potential drug interactions with drugs used for bipolar disorder: a comparison of 6 drug interaction database programs","volume":"53","author":"Monteith S","year":"2020","unstructured":"Monteith S, Glenn T, Gitlin M, Bauer M. Potential drug interactions with drugs used for bipolar disorder: a comparison of 6 drug interaction database programs. Pharmacopsychiatry. 2020, 53:220-7. 10.1055\/a-1156-4193","journal-title":"Pharmacopsychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/76617-potential-psychotropic-and-covid-19-drug-interactions-a-comparison-of-integrated-evidence-from-six-database-programs","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:13Z","timestamp":1707507193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/76617-potential-psychotropic-and-covid-19-drug-interactions-a-comparison-of-integrated-evidence-from-six-database-programs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.20319","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,10]]}}}